Simcyp Limited Develops Dog Simulator for Virtual Preclinical Absorption Studies
SHEFFIELD, England--(BUSINESS WIRE)--Simcyp Limited today announces that it has extended the capabilities of its animal Simulator allowing modelling and simulation studies involving the administration and testing of medicines to be performed in the virtual beagle dog. The new features have been implemented at the request of the world’s major pharmaceutical companies which make up the Simcyp Consortium.